Complement fragment C4d deposition in peritubular capillaries in acute humoral rejection after ABO blood group-incompatible human kidney transplantation

Transplantation. 2003 Mar 15;75(5):663-5. doi: 10.1097/01.TP.0000053402.87256.6B.

Abstract

Background: Acute humoral rejection (AHR) is the most important risk factor for early graft loss in ABO-incompatible (ABO-i) kidney transplantation (RTx). The pathogenesis and diagnostic criteria for AHR after ABO-i RTx remain unclear. Complement fragment C4d deposition in peritubular capillaries (PTC), which is a sensitive indicator for activation of the classical complement pathway, was studied to establish the pathologic diagnostic indicator of AHR.

Methods: Forty-four graft biopsy specimens from 19 patients with ABO-i living donors were analyzed within 90 days after RTx. Nineteen biopsy specimens with acute rejection after ABO-compatible (ABO-c) living-related RTx were used as controls. Diffuse and bright C4d deposition in PTC was considered significantly positive.

Results: All of 8 recipients with AHR showed significantly positive C4d in PTC in the ABO-i group, but 9 of 11 recipients without AHR were negative. In the ABO-c RTx group, 16 of 19 recipients were negative for C4d in PTC. The prevalence of C4d in PTC was significantly higher in ABO-i RTx (P<0.05).

Conclusions: C4d deposition is valuable as a specific and sensitive indicator for AHR, even of mild severity, in ABO-i RTx.

MeSH terms

  • ABO Blood-Group System*
  • Acute Disease
  • Blood Group Incompatibility*
  • Capillaries / metabolism
  • Complement C4 / metabolism*
  • Complement C4b*
  • Control Groups
  • Graft Rejection / metabolism*
  • Humans
  • Kidney Transplantation / immunology*
  • Kidney Tubules / blood supply*
  • Peptide Fragments / metabolism*

Substances

  • ABO Blood-Group System
  • Complement C4
  • Peptide Fragments
  • Complement C4b
  • complement C4d